GGrantIndex
Sort

172,184 grants matching inflammation

Protozoan Population Genetics and Inflammation

$995,544
Michael Grigg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Abdominal Symptom Phenotypes: Pathways to New Biomarkers

$995,519
Margaret McLean Heitkemper · University Of Washington · RC2 · FY2009 · NR

Deciphering Biological Linkages Between PTSD and Respiratory Disease in WTC Respo

$995,508
Benjamin J Luft · State University New York Stony Brook · U01 · FY2015 · OH

Multicenter Osteoarthritis Study (MOST) Second Renewal - UAB Clinical Center

$995,460
Cora E Lewis · University Of Alabama At Birmingham · U01 · FY2017 · AG

Quantitative Neuroimaging Assessment of White Matter Integrity in the Context of Aging and AD

$995,445
Andreana Benitez · Medical University Of South Carolina · R01 · FY2025 · AG

Development of anti-sense oligonucleotides as a therapeutic for cancer pain through selective block of sodium channel pain targets

$995,305
Hongkang Zhang · Quiver Bioscience Inc. · R44 · FY2022 · CA

Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation

$995,121
Craig Gelfand · Advent Therapeutics, Inc. · R44 · FY2023 · HL

Computer Integrated Systems for Microscopy & Manipulation

$995,045
Richard Superfine · Univ Of North Carolina Chapel Hill · P41 · FY2012 · EB

Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleoside Salvage Pathway to Treat Systemic Lupus Erythematosus

$994,978
Kenneth Schultz · Trethera Corporation · R44 · FY2025 · AI

Tumor Immune Contexture and Breast Cancer Disparities: A Multi-Disciplinary Study in Women of African and European Ancestry

$994,901
Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA

Opiate drug abuse and CNS vulnerability to HIV

$994,858
Kurt Francis Hauser · Virginia Commonwealth University · P01 · FY2007 · DA

The small intestinal microbiota in undernourished women and undernourished children in Bangladesh: identifying causal mechanisms and therapeutic targets

$994,651
Jeffrey Ivan Gordon · Washington University · R01 · FY2024 · DK

Development of Clinical Prediction Models for Pulmonary Outcomes in Sarcoidosis

$994,512
Laura L Koth · University Of California, San Francisco · R01 · FY2025 · HL

A Single-cell Platform for Analyzing the Peripheral Immune Response in Alzheimer’s and Alzheimer’s Related Diseases

$994,372
Timothy S McConnell · Isoplexis, Inc. · R44 · FY2021 · AG

Project 4: Longitudinal Brain Imaging for Alzheimer's Biomarkers across Peri to Post Menopausal Transition: Therapeutic Targets and Windows

$994,350
Lisa Mosconi · University Of Arizona · P01 · FY2025 · AG

Functions of IKKalpha in Skin Homeostasis and Skin Tumorigenesis

$994,328
Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Sociodemographic Disparities in SLE Incidence: Behavioral and Psychosocial Factors

$994,269
Karen H Costenbader · Brigham And Women'S Hospital · R01 · FY2017 · AR

A Novel IL-35 Expressing Probiotic Platform for Inducing Allergen Specific Tolerance

$994,179
Neil A Fanger · Virtici, Llc · R44 · FY2021 · AI

Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease

$994,162
Charles T Roberts · Oregon Health & Science University · R01 · FY2023 · DK

FUNCTIONAL DEVELOPMENT OF THE MAMMARY GLAND

$993,945
University Of Colorado Denver · P01 · FY2004 · HD

Modulation of Airway Inflammation in Asthma Models

$993,940
Boston University Medical Campus · P01 · FY2005 · AI

Aerosolized Vitamin A: Developing a Prevention for Hyperoxic Lung Injury and Bronchopulmonary Dysplasia, with Focus on Neonatal Lung Maturation

$993,934
Craig Gelfand · Advent Therapeutics, Inc. · R44 · FY2024 · HL

STING Activators as Therapy for Cancer

$993,879
Glen N Barber · Stinginn, Llc · R42 · FY2023 · CA

Improving marginal allograft outcomes through cell junction stabilization in transplantation

$993,803
Christina Grek · Xequel Bio, Inc. · R44 · FY2021 · DK

TRANSFER OF RESILIENCE TO INFECTION-INDUCED INFLAMMATION FROM MICE TO HUMANS

$993,800
The General Hospital Corporation · · FY2013 · Department of Defense